Markets:

Overview

News

Currencies

International

Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

4.830 -0.150 (-3.01%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Dow Drops 100 Points; IronSource Shares Spike Higher ↗

July 13, 2022

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving higher on Wednesday. The annual inflation rate in the US increased to 9.1% in June, the highest level...

Via Benzinga

Mizuho On Atara Biotherapeutics - Distinguish Between Small Numbers And Science Failure ↗

July 13, 2022

Via Benzinga

Where Atara Biotherapeutics Stands With Analysts ↗

July 13, 2022

Atara Biotherapeutics (NASDAQ:ATRA) has observed the following analyst ratings within the last quarter:

Via Benzinga

Nasdaq Turns Higher; Delta Air Lines Earnings Miss Estimates ↗

July 13, 2022

U.S. stocks pared some losses midway through trading, with the Nasdaq Composite turning higher on Wednesday. The annual inflation rate in the US increased to 9.1% in June, the highest level since...

Via Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

Atara Biotherapeutics Shares Are Plummeting - Read Why ↗

July 13, 2022

Via Benzinga

U.S. Stocks Are Trading Lower As Inflation Rate Accelerates To This Level ↗

July 13, 2022

U.S. stocks traded lower this morning following the release of inflation data for June.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022 ↗

July 13, 2022

Upgrades

Via Benzinga

Read Why Did HC Wainwright Cut Price Target On Atara Biotherapeutics ↗

May 23, 2022

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 13, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 13, 2022

Good morning, investors! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

This Healthcare Stock is Down By More Than 50%: Here's 25 Stocks Moving Premarket ↗

July 13, 2022

Gainers

Via Benzinga

Boeing, PriceSmart And 80 Biggest Movers From Yesterday ↗

July 13, 2022

Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 12, 2022

Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.

Via Benzinga

Atara Biotherapeutics Announces Completion of the ATA188 Phase 2 EMBOLD Study Interim Analysis in Patients with Progressive MS

July 12, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 08, 2022

Via Benzinga

Atara Biotherapeutics to Announce Completion of ATA188 Phase 2 EMBOLD Study Interim Analysis on Tuesday, July 12, 2022

July 06, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 01, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Dow Jumps 150 Points; Icosavax Shares Plunge ↗

June 29, 2022

U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 150 points on Wednesday.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Atara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expanded Access Program (EAP) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and Update on Tab-cel EMA Regulatory Progress

June 04, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 03, 2022

From Atara Biotherapeutics, Inc.

Via Business Wire

Where Atara Biotherapeutics Stands With Analysts ↗

May 24, 2022

Over the past 3 months, 4 analysts have published their opinion on Atara Biotherapeutics (NASDAQ:ATRA) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Atara Biotherapeutics: Here's What You Need To Know ↗

May 23, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Atara Biotherapeutics (NASDAQ:ATRA) and lower its price target from $31.00 to $29.00. Shares of Atara Biotherapeutics are trading down 3.1%...

Via Benzinga

The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗

May 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 20, 2022

Via Benzinga

Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara ↗

May 20, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 19, 2022

Gainers Radius Health (NASDAQ:RDUS) stock moved upwards by 18.8% to $6.94 during Thursday's after-market session. The company's market cap stands at $330.1 million.

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

All News about Atara Biotherapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today